연구동향 분석

ORiginal Article : Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C

( Yuki Wada ) ( Hideyuki Tamai ) ( Akira Kawashima ) ( Naoki Shingaki ) ( Yoshiyuki Mori ) ( Masanori Kawaguchi ) ( Kosaku Moribata ) ( Hisanobu Deguchi ) ( Kazuki Ueda ) ( Izumi Inoue ) ( Takao Maekita ) ( Mikitaka Iguchi ) ( Jun 2014년

논문상세정보
인용/피인용
' ORiginal Article : Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 기초의학
  • aminoacidsubstitution
  • hepatitis c virus
  • peginterferonalfa-2b
  • ribavirin
  • single nucleotide polymorphisms
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
681 0

0.0%

' ORiginal Article : Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C' 의 참고문헌

  • Usefulness of a new immuno-radiometric assay to detect hepatitis C core antigen in a community-based population
    Hayashi K J Viral Hepat 12 : 106 ~ 110 - [2005]
  • Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
    Kumada H J Hepatol 56 : 78 ~ 84 - [2012]
  • Telaprevir and peginterferon with or without ribavirin for chronic HCV infection
    Hézode C N Engl J Med 360 : 1839 ~ 1850 [2009]
  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
    Akuta N J Hepatol 46 : 403 ~ 410 - [2007]
  • Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
    Enomoto N N Engl J Med 334 : 77 ~ 81 - [1996]
  • Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response
    Clark PJ J Viral Hepat 19 : 332 ~ 340 - [2012]
  • Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection
    Li JH Hepatology 51 : 1904 ~ 1911 - [2010]
  • Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis
    Cardoso AC J Hepatol 52 : 652 ~ 657 - [2010]
  • Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments
    kros PJ Hepatology 52 : 1193 ~ 1200 [2010]
  • Guidelines for the management of hepatitis C virus infection: first edition, May 2012
  • Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    Tanaka Y Nat Genet 41 : 1105 ~ 1109 - [2009]
  • Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C
    Hayashi N J Viral Hepat 19 : e134 ~ e142 - [2012]
  • Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis
    Ikeda K Hepatology 29 : 1124 ~ 1130 - [1999]
  • EASL Clinical Practice Guidelines: management of hepatitis C virus infection
    European Association for the Study of the Liver J Hepatol 55 : 245 ~ 264 [2011]
  • Diagnosis, management, and treatment of hepatitis C: an update
    Ghany MG Hepatology 49 : 1335 ~ 1374 - [2009]
  • Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1
    Akuta N J Med Virol 84 : 1097 ~ 1105 - [2012]
  • Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma
    Hu KQ Am J Gastroenterol 99 : 860 ~ 865 - [2004]
  • Clinical characteristics of null responders to Peg-IFNalpha2b/ribavirin therapy for chronic hepatitis C
    Suzuki H World J Hepatol 2 : 401 ~ 405 [2010]
  • Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
    Simmonds P J Gen Virol 74 (Pt 11) : 2391 ~ 2399 - [1993]
  • Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy
    Akuta N Intervirology 48 : 372 ~ 380 - [2005]
  • Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
    Singal AK Clin Gastroenterol Hepatol 8 : 192 ~ 199 - [2010]
  • An algorithm for the grading of activity in chronic hepatitis C
    Bedossa P Hepatology 24 : 289 ~ 293 - [1996]
  • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
    McHutchison JG Gastroenterology 123 : 1061 ~ 1069 - [2002]